Atlas Trials

89bio, Inc.

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch 89bio, Inc.

RecordFirmDate
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH (NCT06419374)89bio, Inc.2024-05-24
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis) (NCT06318169)89bio, Inc.2024-03-13
To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia (NCT05852431)89bio, Inc.2023-06-15
PK Study of Liquid Formulation of BIO89-100 in Subjects With NASH With Compensation Cirrhosis (NCT05022693)89bio, Inc.2021-08-16
Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH) (NCT04929483)89bio, Inc.2021-06-04
Study to Explore the Efficacy and Safety of BIO89-100 (Pegozafermin) in Participants With Severe Hypertriglyceridemia (NCT04541186)89bio, Inc.2020-09-01
A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH (NCT04048135)89bio, Inc.2019-07-29

Track 89bio, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.